Infinity Pharmaceuticals, Inc.
INFIQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.75M | 25.74M | 38.31M | 47.18M | 56.58M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.79M | 2.04M | 1.43M | 1.77M | 2.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 377.00K | 590.00K | 560.00K | 403.00K | 389.00K |
| Total Current Assets | 19.91M | 28.36M | 40.30M | 49.35M | 59.61M |
|
|
|||||
| Total Current Assets | 19.91M | 28.36M | 40.30M | 49.35M | 59.61M |
| Net Property, Plant & Equipment | 1.08M | 1.29M | 1.50M | 1.70M | 1.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 242.00K | 296.00K | 352.00K | 542.00K | 343.00K |
| Total Assets | 21.23M | 29.95M | 42.15M | 51.59M | 61.86M |
|
|
|||||
| Total Accounts Payable | 1.50M | 1.94M | 4.41M | 1.95M | 1.81M |
| Total Accrued Expenses | 8.63M | 7.43M | 7.41M | 10.75M | 10.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.89M | 1.92M | 1.81M | 1.50M | 1.61M |
| Total Finance Division Other Current Liabilities | 45.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 45.00K | -- | -- | -- | -- |
| Total Current Liabilities | 12.06M | 11.29M | 13.63M | 14.20M | 14.34M |
|
|
|||||
| Total Current Liabilities | 12.06M | 11.29M | 13.63M | 14.20M | 14.34M |
| Long-Term Debt | 46.57M | 46.78M | 47.21M | 47.75M | 47.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 164.00K | 324.00K | 480.00K | 633.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 38.00K | 37.00K | 32.00K | 37.00K |
| Total Liabilities | 58.64M | 58.27M | 61.20M | 62.47M | 62.96M |
|
|
|||||
| Common Stock & APIC | 839.55M | 838.68M | 836.90M | 835.85M | 834.92M |
| Retained Earnings | -876.95M | -867.00M | -855.95M | -846.72M | -836.01M |
| Treasury Stock & Other | -- | -- | -- | -- | -18.00K |
| Total Common Equity | -37.41M | -28.32M | -19.05M | -10.87M | -1.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.41M | -28.32M | -19.05M | -10.87M | -1.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.41M | -28.32M | -19.05M | -10.87M | -1.11M |
|
|
|||||